The Scientist

» pharmaceuticals and disease/medicine

Most Recent

image: Year in Review: Hot Topics

Year in Review: Hot Topics

By | December 21, 2015

In 2015, The Scientist dove deep into the latest research on aging, HIV, hearing, and obesity.

0 Comments

image: When the Flu Vax Fails

When the Flu Vax Fails

By | December 16, 2015

The status of a person’s immune system can predict when a seasonal flu vaccination will not provide sufficient protection, according to a study. 

0 Comments

image: First Dengue Vax Approved

First Dengue Vax Approved

By | December 11, 2015

Mexico’s health ministry has OKed the vaccine for people between nine and 45 years old.

0 Comments

image: Global Food-Related Disease Estimate

Global Food-Related Disease Estimate

By | December 7, 2015

More than 400,000 people—including 125,000 children—die from foodborne illness every year, according to the World Health Organization.

0 Comments

image: The Regenerator

The Regenerator

By | December 1, 2015

In his search for effective therapies for Parkinson’s disease, Lorenz Studer is uncovering pluripotency switches and clues to what makes cells age.

0 Comments

image: BRCA1 Linked to Alzheimer’s

BRCA1 Linked to Alzheimer’s

By | November 30, 2015

The cancer-related protein BRCA1 is important for learning and memory in mice and is depleted in the brains of Alzheimer’s patients, according to a study.

0 Comments

image: Cortical Census

Cortical Census

By | November 26, 2015

Scientists document the characteristics and connections of mouse neocortical neurons to establish the most detailed microcircuit map to date.

1 Comment

image: Daraprim Discounts Offered

Daraprim Discounts Offered

By | November 26, 2015

Turing Pharmaceuticals will soon offer discounts to hospitals for its toxoplasmosis-fighting drug, the company announced, but some say the proposed price reductions are not enough.

0 Comments

image: Fatal-Disease Drug in Limbo

Fatal-Disease Drug in Limbo

By | November 25, 2015

A panel of experts advised the US Food and Drug Administration that BioMarin Pharmaceutical has not demonstrated efficacy of its new drug for Duchenne muscular dystrophy.

0 Comments

image: Pfizer and Allergan to Merge

Pfizer and Allergan to Merge

By | November 23, 2015

The two drugmakers will join forces in a $160 billion deal—if it’s given the regulatory green light.

0 Comments

Popular Now

  1. Next Generation: Nanotube Scaffolds Reconnect Spinal Neurons
  2. Mapping the Human Connectome
    Daily News Mapping the Human Connectome

    A new map of human cortex combines data from multiple imaging modalities and comprises 180 distinct regions.

  3. Stroke Alters Gut Microbiome, Impacting Recovery
  4. Your Office Has a Distinct Microbiome
RayBiotech